- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT05029804
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
The Effect of Walking Exercise Training Based on the Theoretical Model on Adherence to Disease Management and Metabolic Control in Type 2 Diabetes Patients: A Clinical Randomized Controlled Study
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Typ studiów
Zapisy (Oczekiwany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Gulengul Mermer, Ph.D
- Numer telefonu: +902323115536
- E-mail: gulengulmermer@gmail.com
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
Patients who diagnosed with type 2 diabetes at least 6 months. Received insulin and/or oral antidiabetic treatment, literate, and having no communication problems, between the ages of 18 and 65, whose arterial blood pressure is in range of systolic ≤ 160mmHg and diastolic ≤ 100mmHg, who had HbA1c between 7-9 % will be included in the study. The patients who agree to participate in the study (voluntarily) and who have no objection to exercising with cardiology consultation will be included in the study.
Exclusion Criteria:
Participants with diabetes-related (severe) complications and diabetic foot, pregnancy, diagnosed with cancer, having physical and mental problems that prevent walking will be excluded from the study. HA1C over 9 - despite the treatment (will be referred to the doctor for treatment change). Patients with blood sugar above 300 - despite treatment (will be referred to their doctor for a change in treatment).
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Intervention Group
After the initial assessment, patients in this group will be educated by the researcher on walking exercise by using the transtheoritical model. The data will be collected from the patients in the experimental group at baseline, 1st, 3rd, and 6th months of the programme. The data will be collected by using Exercise Stages of Change Questionnaire, Exercise Processes of Change Scale, Pedometer, Patient Compliance in Type 2 Diabetes Mellitus Treatment Scale, and patient identification that includes five domain. These domains include questions about the patients' sociodemographic characteristics, habits, knowledge of diabetes and its treatment, exercise status, and the evaluation of the metabolic control variables. |
This intervention will be applied to the patients in the experimental group.
The education will be provided by the researcher and based on the transtheoritical model.
Printed materials and PowerPoint presentations will be used for the education and the education will be conducted in a face-to-face session with each participant (10 weeks).
|
|
Brak interwencji: Control
No intervention will be applied to this group. The data will be collected from the patients in the control group at baseline, 1st, 3rd, and 6th months. The data will be collected by using Exercise Stages of Change Questionnaire, Exercise Processes of Change Scale, Pedometer, Patient Compliance in Type 2 Diabetes Mellitus Treatment Scale, and patient identification that includes five domain. These domains included questions about the patients' sociodemographic characteristics, habits, knowledge of diabetes and its treatment, exercise status, and the evaluation of the metabolic control variables. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Metabolic Parameters 1
Ramy czasowe: The change in 6 months from baseline
|
Fasting Blood Glucose (mg/dL), the fasting blood glucose will be assessed by taking blood sample from the patients.sample
from the patients.
|
The change in 6 months from baseline
|
|
Metabolic Parameters 2
Ramy czasowe: The change in 6 months from baseline
|
HbA1c (both % and mmol/mol), the HbA1c will be assessed by taking blood sample from the patients.
|
The change in 6 months from baseline
|
|
Metabolic Parameters 3
Ramy czasowe: The change in 6 months from baseline
|
Total cholesterol (mg/dL), the total cholesterol will be assessed by taking blood sample from the patients.
|
The change in 6 months from baseline
|
|
Metabolic Parameters 4
Ramy czasowe: The change in 6 months from baseline
|
Creatinine (mg/dL), the creatinine will be assessed by taking blood sample from the patients.
|
The change in 6 months from baseline
|
|
Exercise Stages of Change Questionnaire
Ramy czasowe: The change in 6 months from baseline
|
Prochaska et al. (1992) studied how people change.
Marcus et al. developed a structured questionnaire to measure the stages of exercise changes.
Ay and Temel (2015) adapted the questionnaire to Turkish society.
The scale consists of five questions about the patient's stage of change (prethinking, thinking, preparation, taking action, and maintenance).
In the pre-thinking stage, the patients do not plan to start exercise now or during the next 6 months.
The patients in the thinking stage do not make an effort to exercise actively, but intend to start in the next 6 months.
The patients in the preparation stage intend to start exercising regularly in the next 30 days.
The patients in the taking action stage have started exercising within the last 6 months.
The patients in the maintenance stage continue to change over the course of the action, exercise more than 6 months and are confident and determined not to return to previous behavior.
|
The change in 6 months from baseline
|
|
Exercise Processes of Change Scale
Ramy czasowe: The change in 6 months from baseline
|
The exercise processes of change scale was developed by Marcus et al. and adapted to Turkish society by Ay and Temel.
Exercise processes of change is based on a 5-point Likert type scale and consists of 28 items.
The maximum score that a patient can obtain on the scale is 140, the minimum score is 28.
The scale consists of 10 sub-dimensions and two main processes (behavioral and cognitive).
Behavioral processes are opposition, helping relationships, empowerment management, self-emancipation and stimulus control.
Cognitive processes are increased awareness, dramatic help, environmental reassessment, self reassessment, social independence.
The higher the scale score is indicates a higher success of the change.
In this study, the general Cronbach alpha reliability coefficient of the scale was determined as 0.96 (behavioral process = 0.94 and cognitive process = 0.93).
|
The change in 6 months from baseline
|
|
Patient Compliance in Type 2 Diabetes Mellitus Treatment Scale
Ramy czasowe: The change in 6 months from baseline
|
This scale consists of 30 questions and a five-point Likert type rating is used.
There are 13 positive and 17 negative items in the scale.
Scoring ranges from 1 to 5 for positive items, and reverse scoring ranges from 5 to 1 for negative items.
The highest score obtained from the scale is 150, the lowest score is 30.
30-54 points from the scale indicates "good adherence to treatment", 55-125 points "medium adherence to treatment", and 126-150 points indicate that the patient's adherence to treatment is poor.
The scale was developed by Demirtaş and Albayrak for use in Turkish society.
Cronbach's alpha value was found to be 0.77.
|
The change in 6 months from baseline
|
|
Pedometer
Ramy czasowe: The change in 6 months from baseline
|
A pedometer is a portable, small, inexpensive, and objective tool used to measure the number of steps.
The pedometer includes a mechanical motion sensitive sensor that detects movements during walking.
To prevent diseases and encourage healthy lifestyles, 150 minutes exercise and 10,000 steps per day are recommended.
The researcher will provide participants with Omron brand HJ-320-E model pedometers to record 7days of activity data.
These records were used to calculate the average number of steps per day.
|
The change in 6 months from baseline
|
Współpracownicy i badacze
Sponsor
Śledczy
- Dyrektor Studium: Gulengul Mermer, Ege Uninersity
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Oczekiwany)
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- Type2DiabetesEge
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Cukrzyca typu 2
-
Assiut UniversityJeszcze nie rekrutacjaDiabtes Mellitus Type 1
-
Leiden University Medical CenterZakończonyGruczolak przysadki | Guz przysadki | Diabetes Insipidus Cranial Type | Dokrewny; NiedobórHolandia
-
Fondazione Policlinico Universitario Agostino Gemelli...Jeszcze nie rekrutacjaOtyłość | Cukrzyca typu 2 | Cukrzyca insulinoodporna (Mellitus)
-
Centre Hospitalier Universitaire de LiegeSanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... i inni współpracownicyZakończonyWrodzony przerost nadnerczy | Hemofilia A | Hemofilia B | Mukopolisacharydoza I | Mukopolisacharydoza II | Mukowiscydoza | Niedobór alfa 1-antytrypsyny | Anemia sierpowata | Anemia Fanconiego | Przewlekła choroba ziarniniakowa | Choroba Wilsona | Ciężka wrodzona neutropenia | Niedobór transkarbamylazy ornityny | Mukopolisacharydoza... i inne warunkiBelgia
-
UK Kidney AssociationRekrutacyjnyZapalenie naczyń | AL Amyloidoza | Stwardnienie guzowate | Choroba Fabry'ego | Cystynuria | Ogniskowe segmentowe stwardnienie kłębuszków nerkowych | Nefropatia IgA | Syndrom Barttera | Czysta aplazja czerwonokrwinkowa | Nefropatia błoniasta | Atypowy zespół hemolityczno-mocznicowy | Autosomalna dominująca policystyczna... i inne warunkiZjednoczone Królestwo
Badania kliniczne na Education
-
Universidad de GranadaRejestracja na zaproszenie
-
Burdur Mehmet Akif Ersoy UniversityJeszcze nie rekrutacja
-
Tarsus UniversityZakończony
-
Fundacion para la Investigacion y Formacion en...Rejestracja na zaproszeniePOChP (przewlekła obturacyjna choroba płuc)Hiszpania
-
Changzhou No.2 People's HospitalRekrutacyjny
-
National Taiwan University HospitalJeszcze nie rekrutacjaUSG w punkcie opieki | Przedszpitalne Ratownictwo Medyczne
-
Chang Gung Memorial HospitalNational Taipei University of Nursing and Health SciencesRekrutacyjny
-
University of North Texas Health Science CenterNational Institute on Minority Health and Health Disparities (NIMHD)ZakończonyOtyłość | Styl życia, zdrowy | Zmiany behawioralneStany Zjednoczone
-
Nordsjaellands HospitalLund University; Region Capital Denmark; Ostfold University College; University... i inni współpracownicyRekrutacyjnySzpitalDania, Norwegia, Szwecja
-
State University of New York at BuffaloAktywny, nie rekrutującyCukrzyca typu 2Stany Zjednoczone